Formulation of cerium oxide nanoparticles towards the prevention and treatment of cataract

Hanafy, B.I., 2020. Formulation of cerium oxide nanoparticles towards the prevention and treatment of cataract. PhD, Nottingham Trent University.

Final thesis 4-3-2020 after corrections (no highlights).pdf - Published version

Download (15MB) | Preview


Chronic diseases are rising in incidence and prevalence because of the increase in life expectancy in many parts of the world and the advances in medicine that manage disease progression, rather than curing and alleviating the causes. Cataract is one such chronic condition. Identifying a therapeutic intervention that is successful in reversing or preventing cataracts may have applications for other chronic diseases of protein misfolding, such as diabetes and Alzheimer's disease as these have similar causation factors, notably oxidative stress and/or glycation. To date, surgery remains the only effective treatment for cataract and the search for alternatives is still ongoing. Cerium oxide nanoparticles (nanoceria) which have antioxidant, radioprotective and enzyme-mimetic properties have the potential to lead to an effective non-surgical treatment. However, nanoceria stability in physiological media is poor thus hindering their effective use in biomedical applications. In the work described in this thesis, a highly efficient one-pot synthesis of nanoceria (2–5 nm) has been achieved. The nanoparticles were coated with a novel hybrid coating (ethylene glycol, ethylene glycol monoand di- acetates) providing the formulation with superior colloidal stability in physiological media. The ethylene glycol coated nanoceria formulation (EGCNPs), up to concentrations of 200 μg/ml, is not toxic to human lens epithelial cells and has no adverse effect on the cellular morphology, proliferation rate, mitochondrial morphology, mitochondrial membrane potential, ATP level, DNA integrity and basal reactive oxygen species (ROS) level. Exceeding the safe concentration of nanoceria leads to genotoxicity and apoptotic cell death mediated by ROS elevation and mitochondrial damage, a mechanism which is comprehensively investigated for the first time in human lens epithelial cells (HLECs). EGCNPs uptake in HLECs was found to be endocytosisdependent and the nanoparticles localised extensively in the mitochondria. This localisation has enabled the nanoparticles to protect HLECs against oxidative stress, act as a catalase mimetic and increase reduced glutathione/oxidised glutathione ratio (GSH/GSSG). Furthermore, it is shown for the first time that these nanoparticles can protect lens proteins against glucose-induced glycation that is a major cause of cataract particularly in diabetics. Together, these results demonstrate great potential for nanoceria in protecting against cataract and should be taken to in-vivo studies.

Item Type: Thesis
Creators: Hanafy, B.I.
Date: March 2020
Rights: This work is the intellectual copyright of the author. You may copy up to 5% of this work for private study, or personal, non-commercial research. Any re-use of the information contained within this document should be fully referenced, quoting the author, title, university, degree level and pagination. Queries or requests for any other use, or if a more substantial copy is required, should be directed in the first instance to the owner of the Intellectual Property.
Divisions: Schools > School of Science and Technology
Record created by: Jeremy Silvester
Date Added: 05 Nov 2020 14:36
Last Modified: 31 May 2021 15:14

Actions (login required)

Edit View Edit View


Views per month over past year


Downloads per month over past year